Ally Bridge Group (NY) LLC Quant / Systematic

Location: New York, NY

CIK: 0001822947 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 14, 2024

Total Value: $168M (100.0% shares, 0.0% debt)

Holdings (25)

SLNO SOLENO THERAPEUTICS INC 7.0%
Value $11.68M Shares 286,162 Est. Cost $29.77 Unrealized +42.3%
SRPT SAREPTA THERAPEUTICS INC 6.9%
Value $11.61M Shares 73,500 Est. Cost $128.46 Unrealized 0.0%
GERN GERON CORP 6.9%
Value $11.6M Shares 2,736,663 Est. Cost $2.61 Unrealized +49.2%
MERUS N V 6.2%
Value $10.35M Shares 174,844 Est. Cost $20.59 Unrealized
INSM INSMED INC 5.1%
Value $8.643M Shares 129,000 Est. Cost $27.99 Unrealized +38.6%
LEGN LEGEND BIOTECH CORP 5.1%
Value $8.637M Shares 195,000 Est. Cost $44.29 Unrealized
ALMS ALUMIS INC 4.9%
Value $8.229M Shares 618,750 Est. Cost $13.30 Unrealized 0.0%
BLUEPRINT MEDICINES CORP 4.9%
Value $8.152M Shares 75,638 Est. Cost $94.86 Unrealized
IRON DISC MEDICINE INC 4.5%
Value $7.504M Shares 166,500 Est. Cost $33.98 Unrealized 0.0%
DAWN DAY ONE BIOPHARMACEUTICALS I 4.4%
Value $7.387M Shares 536,095 Est. Cost $14.63 Unrealized 0.0%
MIND MEDICINE MINDMED INC 4.1%
Value $6.961M Shares 965,426 Est. Cost $9.40 Unrealized
XENE XENON PHARMACEUTICALS INC 3.9%
Value $6.604M Shares 169,369 Est. Cost $38.92 Unrealized +2.7%
PRAX PRAXIS PRECISION MEDICINES I 3.8%
Value $6.344M Shares 153,379 Est. Cost $33.00 Unrealized +43.2%
KURA KURA ONCOLOGY INC 3.8%
Value $6.316M Shares 306,762 Est. Cost $19.44 Unrealized +5.7%
AVADEL PHARMACEUTICALS PLC 3.6%
Value $6.049M Shares 430,245 Est. Cost $14.06 Unrealized
LONGBOARD PHARMACEUTICALS IN 3.5%
Value $5.919M Shares 218,981 Est. Cost $21.60 Unrealized
CGON CG ONCOLOGY INC 3.3%
Value $5.521M Shares 174,876 Est. Cost $40.84 Unrealized -15.1%
JSPR JASPER THERAPEUTICS INC 3.0%
Value $4.963M Shares 218,614 Est. Cost $17.76 Unrealized +35.0%
TRVI TREVI THERAPEUTICS INC 2.6%
Value $4.395M Shares 1,474,926 Est. Cost $2.78 Unrealized 0.0%
TYRA TYRA BIOSCIENCES INC 2.5%
Value $4.232M Shares 264,660 Est. Cost $17.21 Unrealized 0.0%
CATX PERSPECTIVE THERAPEUTICS INC 2.4%
Value $3.951M Shares 396,242 Est. Cost $14.46 Unrealized 0.0%
BDTX BLACK DIAMOND THERAPEUTICS I 2.3%
Value $3.891M Shares 835,000 Est. Cost $5.37 Unrealized 0.0%
CNTX CONTEXT THERAPEUTICS INC 2.3%
Value $3.782M Shares 1,886,232 Est. Cost $1.40 Unrealized +23.2%
CLYM ELIEM THERAPEUTICS INC 2.1%
Value $3.555M Shares 500,000 Est. Cost $6.66 Unrealized 0.0%
PROMIS NEUROSCIENCES INC 0.9%
Value $1.589M Shares 1,059,582 Est. Cost $1.56 Unrealized